- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03484715
Feasibility of a Physical Activity Programme for Older Adults in Nursing Homes
Feasibility of a Physical Activity Programme Embedded Into the Daily Lives of Older Adults Living in Nursing Homes: a Randomised Controlled Pilot Feasibility Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Physical inactivity is a global health pandemic and is one of four leading contributors to premature mortality. Although there is evidence that physical activity improves short-term function and is safe among older adults of long-term care, the optimum contents of a physical activity programme or how best to implement it remain unclear. Few studies in nursing homes have attempted to increase physical activity levels by incorporating more usual activities into the resident's everyday routine. The proposed pilot feasibility study will implement a person-centred physical activity programme into the participant's daily routine, based on increasing duration and repetitions of everyday functions including walking and rising from a chair. It incorporates key constructs of social cognitive theory and is monitored by nursing home staff who will receive training and support.
Research questions:
This pilot feasibility study will have the following primary research questions:
Is the intervention feasible and acceptable to staff and participants?
- Is the time commitment required for staff to monitor the intervention and participants to partake in the intervention feasible?
- Are there any environmental barriers to completion of the intervention?
- Is the content of the intervention acceptable to participants and staff?
- Do the participants adhere to the intervention and what adherence issues arise?
Are the outcome measures feasible and acceptable to participants?
- What is the required time and number of visits required to collect each outcome from participants?
- Are the outcome measures acceptable to participants?
- What is the level of missing data within the self-reported outcome measures?
What is the required sample size for a definitive randomised?
- What is the baseline score and variability of the primary outcome measure among participants?
- What is the estimated effect size and variance for the primary outcome measure?
- What are the recruitment and attrition rates for nursing homes and participants? Do these rates differ between the intervention and control groups?
The secondary research questions of the pilot study are:
What are the preliminary clinical outcomes and cost-effectiveness of the intervention compared to the control group?
- What are the components of usual care for participants allocated to the control group?
- What are the estimated outcomes of the intervention in comparison with the control group and are these sustained at 12 month follow-up?
- What are the costs of the intervention in comparison to costs in the control group?
- What is the feasibility of collecting health economic data (i.e. sources used and time taken)?
Design:
A randomised controlled pilot feasibility study, including a qualitative and economic component will be carried out. Two randomly selected nursing homes will take part in the study; participants (n=20) in one nursing home will receive the physical activity intervention and participants (n=20) in the other will receive usual care. In order to avoid contamination between intervention and control groups, randomisation will take place at nursing home level. The pilot feasibility study will not be an exact scale model of a definitive RCT, the difference being that outcome assessment will not be blinded as a full analysis of outcome data is not intended. However, the recruitment, randomisation, assessment and intervention conditions will be similar to a definitive RCT in order to answer the feasibility research questions. Quantitative outcome data will be collected in an unblinded manner from participants at T1 (baseline, pre-intervention), T2 (directly after completion of the intervention at 4 months) to examine the immediate intervention outcomes and T3 (12 months following the start of the intervention) to examine if the outcomes are sustained beyond intervention completion.
Qualitative component:
A qualitative descriptive approach will be taken for the qualitative component of the study. Qualitative data will be collected from participants and staff of the intervention group within 1 month following intervention completion and again with the participants at 7 months following intervention completion. Data will be collected via audio-recorded semi structured one-to-one interviews. The aim of the interviews with participants will be to explore the participant's experiences of receiving the intervention, the feasibility and acceptability of the intervention, the perceived effects of the intervention, including potential adverse effect, and issues around maintenance of the participants' physical activity over time, following intervention completion. The staff interviews will explore the staffs' role and experiences of being involved in the study, including their participation in the staff education sessions and the delivery of the physical activity programmes. Semi-structured qualitative interviews will be conducted with small subset of participants from the control group on two occasions. The first interviews will take place immediately following the recruitment and consent stage of the study, in order to maximise the feasibility data obtained for these study processes. The second interviews will take place upon completion of the 4 month intervention with the objective being to define and describe usual care.
Economic component:
A preliminary estimate of the costs and outcomes of the intervention relative to the usual care control will be assessed using a cost effectiveness analysis and cost utility analysis. Resource use associated with delivery of the physical activity intervention will be measured and costed. Resources used by participants over the course of the study will be recorded in both groups, for example health service usage, medication usage and private expenses relating to the intervention. Data collected from the primary outcome measure, the Timed Up and Go test, at each time point will be used alongside resource usage to provide the basis for the cost effectiveness analysis. For the cost utility analysis, effectiveness will be evaluated on the basis of the Quality Adjusted Life Year which will be estimated using the EuroQol 5 Dimensions 5 Levels instrument, assessed at baseline, 4 month and 12 month follow-up.
Statistical analysis:
SPSS Statistics (24.0 for Windows, Chicago, USA) will be use to analyse quantitative data. Demographical information in both groups will be tabulated and summarised. The effect of the intervention on clinical outcomes will be examined using suitable numerical and graphical summaries. The statistical analysis will serve primarily to provide an estimation of likely effect size and variance of effect size rather than statistical significance. Qualitative data will be analysed using NVivo (QSR International Pty Ltd. Version 11, 2015). Interviews will be transcribed verbatim and analysed using thematic analysis.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Aged 65 or over.
- Can speak and understand English.
- Resident in nursing home for at least 3 months.
- Able to rise from a chair with armrests (with or without a walking aid) and able to walk at least 10 metres (with or without a walking aid) independently or with minimal assistance.
- Approval of the resident's General Practitioner to participate.
- Cognitively capable of providing informed consent to participate, as judged by the key nurse caring for the participant.
- Cognitive function of a score of greater than 20 on the Mini Mental State Examination.
Exclusion Criteria:
- Admission to nursing home for respite or end-stage terminal care.
- A significant sensory impairment, physical impairment or illness that impairs their ability to participate.
- Uncontrolled cardiovascular, musculoskeletal or neurological disorders.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Physical Activity Intervention
Each participant in this arm will outline a small number of activity-related goals and will receive a 4 month personalised physical programme where additional physical activity will be incorporated into their daily routines.
Nursing home staff will receive two educational sessions, which will provide them with the necessary skills to monitor participants physical activity programmes within the nursing home.
|
A physical activity programme will be developed by the researcher for each participant.
Integral to each physical activity programme will be a walking component (i.e.
structured and gradual increases in daily walking time) and sit-to-stand exercises (i.e. a specified number of repeated rises from a chair).
The rest of the physical activity programme will be tailored around each participant's specific functional goal and will be based on repeating particular functional activities.
This programme will take place on 3 days per week in month 1, 4 days per week in month 2 and 3, and 5 days a week in month 4.
|
NO_INTERVENTION: Usual Care Control
The participants in the control arm will receive usual care, which will be guided by current nursing and medical care plans.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Proportion of eligible nursing homes which agree to participate in study
Time Frame: Up to 2 months
|
This will be expressed as a percentage of nursing homes which agree to participate in study out of the nursing homes which were invited to participle in study.
|
Up to 2 months
|
Proportion of eligible nursing home residents which agree to participate in study
Time Frame: Up to 1 month
|
This will be expressed as a percentage of participants which agree to participate in study out of the participants which were invited to participle in study.
|
Up to 1 month
|
Time for recruitment of nursing homes
Time Frame: Up to 2 months
|
This is be defined as time from initial contact with first nursing home to signing of final nursing home participation form and will be expressed as number weeks and days.
|
Up to 2 months
|
Time for recruitment of participants within nursing homes
Time Frame: Up to 1 month
|
This is be defined as time from initial contact with first participant to signing of final participant consent form and will be expressed as number of weeks and days.
|
Up to 1 month
|
Retention rate of nursing homes at 4 month follow-up.
Time Frame: Assessed at 4 month follow-up.
|
This is defined as percentage of nursing homes remaining in study at 4 month follow-up.
|
Assessed at 4 month follow-up.
|
Retention rate of nursing homes at 12 month follow-up
Time Frame: Assessed at 12 month follow-up.
|
This is defined as percentage of nursing homes remaining in the study at 12 month follow-up.
|
Assessed at 12 month follow-up.
|
Retention rate of participants at 4 months
Time Frame: Assessed at 4 month follow-up
|
This is defined as percentage of participants remaining in study at 4 month follow-up.
|
Assessed at 4 month follow-up
|
Retention rate of participants at 12 month follow-up
Time Frame: Assessed at 12 month follow-up.
|
This is defined as percentage of participants remaining in the study at 12 month follow-up.
|
Assessed at 12 month follow-up.
|
Adherence rate of participants to the intervention
Time Frame: Assessed at 4 month follow-up
|
This will provide feasibility data.
This will be expressed as the percentage of participants completing 75% of their physical activity programme according to the participant adherence sheets.
|
Assessed at 4 month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Timed Up and Go Test
Time Frame: This will be assessed at baseline, directly after completion of the intervention at 4 months and at 12 months after the start of the intervention.
|
This is a test of physical mobility and measures the time taken by an individual to stand up from a standard arm chair, walk a distance of 3 metres at a comfortable pace, turn, walk back to the chair, and sit down.
Change in Timed Up and Go score will be measured in seconds.
|
This will be assessed at baseline, directly after completion of the intervention at 4 months and at 12 months after the start of the intervention.
|
Nottingham Health Profile
Time Frame: This will be assessed at baseline, directly after completion of the intervention at 4 months and at 12 months after the start of the intervention
|
This provides a measure of health-related quality of life and change in Nottingham Health Profile score will be evaluated.
The questionnaire measures self-perceived health across six domains: (i) sleep (ii) mobility (iii) energy (iv) pain (v) emotional reactions (vi) social isolation.
Scores range from 0 to 1, with 0 indicating poor health and 1 indicating good health.
There are no subscale scores to be reported.
|
This will be assessed at baseline, directly after completion of the intervention at 4 months and at 12 months after the start of the intervention
|
10 Metre Walk Test
Time Frame: This will be assessed at baseline, directly after completion of the intervention at 4 months and at 12 months after the start of the intervention
|
This is a measure of gait speed and the change in gait speed will be reported in seconds.
The participant will walk 10 metres and the time is measured for the intermediate 6 metres to allow for acceleration and deceleration.
The timer is started when the toes of the leading foot cross the 2-metre mark and stopped when the toes of the leading foot cross the 8-metre mark.
|
This will be assessed at baseline, directly after completion of the intervention at 4 months and at 12 months after the start of the intervention
|
ICEpop CAPability measure for Older people (ICECAP-O)
Time Frame: This will be assessed at baseline, directly after completion of the intervention at 4 months and at 12 months after the start of the intervention.
|
This provides a measure of capability-related quality of life and change in ICECAP-O score will be evaluated.
The scale of this score ranges from 0 to 1, with 0 representing no capability and 1 representing full capability.
There are no subscale scores to be reported.
|
This will be assessed at baseline, directly after completion of the intervention at 4 months and at 12 months after the start of the intervention.
|
Bangor Goal Setting Interview
Time Frame: This will be assessed at baseline, directly after completion of the intervention at 4 months and at 12 months after the start of the intervention
|
In the intervention group only, the participant will rate their current performance and satisfaction with performance for their activity-based goal on a 1-10 Likert scale (where 1 means cannot do or am not doing successfully and 10 means can do and am doing very successfully).
Change in scores will be evaluated.
|
This will be assessed at baseline, directly after completion of the intervention at 4 months and at 12 months after the start of the intervention
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Eva Barrett, PhD, National Univeristy of Ireland, Galway
Publications and helpful links
General Publications
- Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011 Dec;20(10):1727-36. doi: 10.1007/s11136-011-9903-x. Epub 2011 Apr 9.
- Podsiadlo D, Richardson S. The timed "Up & Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991 Feb;39(2):142-8. doi: 10.1111/j.1532-5415.1991.tb01616.x.
- Hallal PC, Andersen LB, Bull FC, Guthold R, Haskell W, Ekelund U; Lancet Physical Activity Series Working Group. Global physical activity levels: surveillance progress, pitfalls, and prospects. Lancet. 2012 Jul 21;380(9838):247-57. doi: 10.1016/S0140-6736(12)60646-1.
- Crocker T, Forster A, Young J, Brown L, Ozer S, Smith J, Green J, Hardy J, Burns E, Glidewell E, Greenwood DC. Physical rehabilitation for older people in long-term care. Cochrane Database Syst Rev. 2013 Feb 28;(2):CD004294. doi: 10.1002/14651858.CD004294.pub3.
- Peri K, Kerse N, Robinson E, Parsons M, Parsons J, Latham N. Does functionally based activity make a difference to health status and mobility? A randomised controlled trial in residential care facilities (The Promoting Independent Living Study; PILS). Age Ageing. 2008 Jan;37(1):57-63. doi: 10.1093/ageing/afm135. Epub 2007 Oct 25.
- Bandura A. Health promotion by social cognitive means. Health Educ Behav. 2004 Apr;31(2):143-64. doi: 10.1177/1090198104263660.
- Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Research in Psychology. 3(2): 77-101, 2006.
- Holthe T, Thorsen K, Josephsson S. Occupational patterns of people with dementia in residential care: an ethnographic study. Scand J Occup Ther. 2007 Jun;14(2):96-107. doi: 10.1080/11038120600963796.
- Barrett E, Gillespie P, Newell J, Casey D. Feasibility of a physical activity programme embedded into the daily lives of older adults living in nursing homes: protocol for a randomised controlled pilot feasibility study. Trials. 2018 Aug 29;19(1):461. doi: 10.1186/s13063-018-2848-4.
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- GOIPD/2017/1301
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Old Age
-
Hallym University Kangnam Sacred Heart HospitalCompleted
-
University of LisbonAssociacao Protectora dos Diabeticos de PortugalCompleted
-
McGill UniversityRéseau québécois de recherche sur le vieillissement; MUHC-Montreal General...Completed
-
Riphah International UniversityRecruitingFall | Old AgePakistan
-
Tabula Rasa HealthCareEnrolling by invitation
-
University Hospital, AngersWithdrawnSatisfaction | Old Age | UsabilityFrance
-
The Hong Kong Polytechnic UniversityNot yet recruitingOld Age | Family Members
-
University of WashingtonNational Institute of Nursing Research (NINR)CompletedFalls (Accidents) in Old AgeUnited States
-
Joel BelminUnknownFalls (Accidents) in Old AgeFrance
-
Samsung Medical CenterCompletedGait Disorders in Old AgeKorea, Republic of
Clinical Trials on Physical Activity Intervention
-
Brown UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
University of ConnecticutNational Institutes of Health (NIH); National Center for Complementary and...RecruitingChronic Low Back PainUnited States
-
Institut Català d'OncologiaUnknownRecurrence | Breast NeoplasmsSpain
-
Centre Leon BerardNational Cancer Institute, FranceNot yet recruitingMetastatic Testicular CancerFrance
-
University of California, DavisActive, not recruitingBehavior, HealthUnited States
-
Jamie JacksonNational Heart, Lung, and Blood Institute (NHLBI)CompletedPhysical Activity | Cardiovascular Disease OtherUnited States
-
Brown UniversityNational Cancer Institute (NCI)Not yet recruiting
-
Jamie JacksonCompletedPhysical Activity | Cardiovascular Disease OtherUnited States
-
The Miriam HospitalUnknownStroke | Sedentary Lifestyle | Ischemic Attack, Transient | ExerciseUnited States
-
Tel-Aviv Sourasky Medical CenterUnknownObesity | Overweight | Learning DisabilityIsrael